cytarabine has been researched along with n-hydroxy-n'-aminoguanidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avramis, VI; Koneru, PB; Lien, EJ | 1 |
| Basu, A; Fritzer-Szekeres, M; Giessrigl, B; Graser, G; Grusch, M; Jaeger, W; Jayaprakash, V; Krupitza, G; Lackner, A; Saiko, P; Sinha, BN; Szekeres, T | 1 |
2 other study(ies) available for cytarabine and n-hydroxy-n'-aminoguanidine
| Article | Year |
|---|---|
Synthesis and testing of new antileukemic Schiff bases of N-hydroxy-N'-aminoguanidine against CCRF-CEM/0 human leukemia cells in vitro and synergism studies with cytarabine (Ara-C).
Topics: Antineoplastic Agents; Cell Division; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Guanidines; Humans; Isoquinolines; Leukemia; Oxidation-Reduction; Schiff Bases; Tumor Cells, Cultured | 1993 |
A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
Topics: Cell Cycle Proteins; Cytarabine; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Guanidines; HL-60 Cells; Humans; Immunoglobulin G; Melphalan; Molecular Structure; Ribonucleotide Reductases; Structure-Activity Relationship | 2011 |